cpt code for asthma control testcpt code for asthma control test

The test code is 96160 provided that you have the documentation to support this code. Cancel anytime. S sjenrette Contributor Messages 14 Location Lawrenceville, GA Best answers 0 Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES Another option is to use the Download button at the top right of the document view pages (for certain document types). The AMA CPT Editorial Panel reviews and responds to requests for additions to or revisions of the CPT. There are multiple ways to create a PDF of a document that you are currently viewing. You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. Question - Asthma Control Test | Medical Billing and Coding Forum - AAPC. Nucala is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). CDT is a trademark of the ADA. 0000158556 00000 n You can collapse such groups by clicking on the group header to make navigation easier. %%EOF The code lists in the article help explain which services (procedures) the related LCD applies to, the diagnosis codes for which the service is covered, or for which the service is not considered reasonable and necessary and therefore not covered. Each CPT code has five digits. Exacerbations: two or more in the past year, especially if FEV 1<50% predicted suggests high risk. (Note: The following example is intended to illustrate documentation Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not Inhalation of some dusts, gases, or other air contaminants in your workplace as well as some personal exposures, such as cigarette smoking, can harm your lungs. In most instances Revenue Codes are purely advisory. 138. Question Asthma Control Test. The AMA assumes no liability for data contained or not contained herein. If so, do you use 96160 with Asthma dx or G9432 or G9434. WebAsthma Control Test TM For patients with asthma ages 12 years and older: a 5-question test to help determine if asthma symptoms are well controlled. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. Your MCD session is currently set to expire in 5 minutes due to inactivity. See our privacy policy. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. The Current Procedural Terminology (CPT ) code 96160 as maintained by American There is not a specific CPT to represent this service. See Indications and Limitations. Oxygenation: severe hypoxemia: resting O2 sat< 88% or arterial pO2<55 mmHg episodic hypoxemia: exercise or nocturnal desaturation. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, Tuberculosis of intrathoracic lymph nodes, Tuberculosis of larynx, trachea and bronchus, Acute miliary tuberculosis of a single specified site, Acute miliary tuberculosis of multiple sites, Malignant neoplasm of right main bronchus, Malignant neoplasm of upper lobe, right bronchus or lung, Malignant neoplasm of upper lobe, left bronchus or lung, Malignant neoplasm of middle lobe, bronchus or lung, Malignant neoplasm of lower lobe, right bronchus or lung, Malignant neoplasm of lower lobe, left bronchus or lung, Malignant neoplasm of overlapping sites of right bronchus and lung, Malignant neoplasm of overlapping sites of left bronchus and lung, Malignant neoplasm of anterior mediastinum, Malignant neoplasm of posterior mediastinum, Malignant neoplasm of overlapping sites of heart, mediastinum and pleura, Secondary malignant neoplasm of right lung, Secondary malignant neoplasm of left lung, Secondary malignant neoplasm of mediastinum, Secondary malignant neoplasm of other respiratory organs, Multifocal and unisystemic Langerhans-cell histiocytosis, Carcinoma in situ of right bronchus and lung, Carcinoma in situ of left bronchus and lung, Carcinoma in situ of other parts of respiratory system, Benign neoplasm of right bronchus and lung, Benign neoplasm of left bronchus and lung, Benign neoplasm of mesothelial tissue of pleura, Neoplasm of uncertain behavior of stomach, Neoplasm of uncertain behavior of small intestine, Neoplasm of uncertain behavior of appendix, Neoplasm of uncertain behavior of trachea, bronchus and lung, Neoplasm of uncertain behavior of mediastinum, Neoplasm of uncertain behavior of other respiratory organs, Sickle-cell thalassemia beta zero with acute chest syndrome, Sickle-cell thalassemia beta plus with acute chest syndrome, Sarcoidosis of lung with sarcoidosis of lymph nodes, Multiple cranial nerve palsies in sarcoidosis, Cystic fibrosis with pulmonary manifestations, Cystic fibrosis with other intestinal manifestations, Cystic fibrosis with other manifestations, Myasthenia gravis without (acute) exacerbation, Myasthenia gravis with (acute) exacerbation, Other inflammatory and immune myopathies, not elsewhere classified, Saddle embolus of pulmonary artery with acute cor pulmonale, Other pulmonary embolism with acute cor pulmonale, Saddle embolus of pulmonary artery without acute cor pulmonale, Single subsegmental pulmonary embolism without acute cor pulmonale, Multiple subsegmental pulmonary emboli without acute cor pulmonale, Other pulmonary embolism without acute cor pulmonale, Secondary pulmonary arterial hypertension, Pulmonary hypertension due to left heart disease, Pulmonary hypertension due to lung diseases and hypoxia, Chronic thromboembolic pulmonary hypertension, Acute systolic (congestive) heart failure, Chronic systolic (congestive) heart failure, Acute on chronic systolic (congestive) heart failure, Acute diastolic (congestive) heart failure, Chronic diastolic (congestive) heart failure, Acute on chronic diastolic (congestive) heart failure, Acute combined systolic (congestive) and diastolic (congestive) heart failure, Chronic combined systolic (congestive) and diastolic (congestive) heart failure, Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure, Attention and concentration deficit following nontraumatic subarachnoid hemorrhage, Memory deficit following nontraumatic subarachnoid hemorrhage, Visuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage, Psychomotor deficit following nontraumatic subarachnoid hemorrhage, Frontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage, Cognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage, Other symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side, Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral, Apraxia following nontraumatic subarachnoid hemorrhage, Dysphagia following nontraumatic subarachnoid hemorrhage, Facial weakness following nontraumatic subarachnoid hemorrhage, Ataxia following nontraumatic subarachnoid hemorrhage, Other sequelae following nontraumatic subarachnoid hemorrhage, Attention and concentration deficit following nontraumatic intracerebral hemorrhage, Memory deficit following nontraumatic intracerebral hemorrhage, Visuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage, Psychomotor deficit following nontraumatic intracerebral hemorrhage, Frontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage, Cognitive social or emotional deficit following nontraumatic intracerebral hemorrhage, Other symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side, Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side, Other paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral, Apraxia following nontraumatic intracerebral hemorrhage, Dysphagia following nontraumatic intracerebral hemorrhage, Facial weakness following nontraumatic intracerebral hemorrhage, Ataxia following nontraumatic intracerebral hemorrhage, Other sequelae of nontraumatic intracerebral hemorrhage, Attention and concentration deficit following other nontraumatic intracranial hemorrhage, Memory deficit following other nontraumatic intracranial hemorrhage, Visuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage, Psychomotor deficit following other nontraumatic intracranial hemorrhage, Frontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage, Cognitive social or emotional deficit following other nontraumatic intracranial hemorrhage, Other symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side, Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side, Other paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral, Apraxia following other nontraumatic intracranial hemorrhage, Dysphagia following other nontraumatic intracranial hemorrhage, Facial weakness following other nontraumatic intracranial hemorrhage, Ataxia following other nontraumatic intracranial hemorrhage, Other sequelae of other nontraumatic intracranial hemorrhage, Attention and concentration deficit following cerebral infarction, Memory deficit following cerebral infarction, Visuospatial deficit and spatial neglect following cerebral infarction, Psychomotor deficit following cerebral infarction, Frontal lobe and executive function deficit following cerebral infarction, Cognitive social or emotional deficit following cerebral infarction, Other symptoms and signs involving cognitive functions following cerebral infarction, Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side, Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side, Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side, Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side, Other paralytic syndrome following cerebral infarction affecting right dominant side, Other paralytic syndrome following cerebral infarction affecting left dominant side, Other paralytic syndrome following cerebral infarction affecting right non-dominant side, Other paralytic syndrome following cerebral infarction affecting left non-dominant side, Other paralytic syndrome following cerebral infarction, bilateral, Facial weakness following cerebral infarction, Attention and concentration deficit following other cerebrovascular disease, Memory deficit following other cerebrovascular disease, Visuospatial deficit and spatial neglect following other cerebrovascular disease, Psychomotor deficit following other cerebrovascular disease, Frontal lobe and executive function deficit following other cerebrovascular disease, Cognitive social or emotional deficit following other cerebrovascular disease, Other symptoms and signs involving cognitive functions following other cerebrovascular disease, Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side, Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side, Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side, Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side, Other paralytic syndrome following other cerebrovascular disease affecting right dominant side, Other paralytic syndrome following other cerebrovascular disease affecting left dominant side, Other paralytic syndrome following other cerebrovascular disease affecting right non-dominant side, Other paralytic syndrome following other cerebrovascular disease affecting left non-dominant side, Other paralytic syndrome following other cerebrovascular disease, bilateral, Apraxia following other cerebrovascular disease, Dysphagia following other cerebrovascular disease, Facial weakness following other cerebrovascular disease, Ataxia following other cerebrovascular disease, Other sequelae of other cerebrovascular disease, Influenza due to identified novel influenza A virus with pneumonia, Influenza due to identified novel influenza A virus with other respiratory manifestations, Influenza due to identified novel influenza A virus with gastrointestinal manifestations, Influenza due to identified novel influenza A virus with other manifestations, Pneumonia due to coronavirus disease 2019, Pneumonia in diseases classified elsewhere, Acute bronchitis due to Mycoplasma pneumoniae, Acute bronchitis due to Hemophilus influenzae, Acute bronchitis due to parainfluenza virus, Acute bronchitis due to respiratory syncytial virus, Acute bronchitis due to other specified organisms, Acute bronchiolitis due to respiratory syncytial virus, Acute bronchiolitis due to human metapneumovirus, Acute bronchiolitis due to other specified organisms, Other specified diseases of upper respiratory tract, Bronchitis, not specified as acute or chronic, Mixed simple and mucopurulent chronic bronchitis, Unilateral pulmonary emphysema [MacLeod's syndrome], Chronic obstructive pulmonary disease with (acute) lower respiratory infection, Chronic obstructive pulmonary disease with (acute) exacerbation, Chronic obstructive pulmonary disease, unspecified, Mild intermittent asthma with (acute) exacerbation, Mild intermittent asthma with status asthmaticus, Mild persistent asthma with (acute) exacerbation, Mild persistent asthma with status asthmaticus, Moderate persistent asthma, uncomplicated, Moderate persistent asthma with (acute) exacerbation, Moderate persistent asthma with status asthmaticus, Severe persistent asthma with (acute) exacerbation, Severe persistent asthma with status asthmaticus, Unspecified asthma with (acute) exacerbation, Unspecified asthma with status asthmaticus, Bronchiectasis with acute lower respiratory infection, Pneumoconiosis due to asbestos and other mineral fibers, Pneumoconiosis due to other dust containing silica, Pneumoconiosis due to other specified inorganic dusts, Pneumoconiosis associated with tuberculosis, Airway disease due to other specific organic dusts, Hypersensitivity pneumonitis due to other organic dusts, Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors, Pulmonary edema due to chemicals, gases, fumes and vapors, Upper respiratory inflammation due to chemicals, gases, fumes and vapors, not elsewhere classified, Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors, Chronic respiratory conditions due to chemicals, gases, fumes and vapors, Other respiratory conditions due to chemicals, gases, fumes and vapors, Pneumonitis due to inhalation of food and vomit, Pneumonitis due to inhalation of oils and essences, Pneumonitis due to inhalation of other solids and liquids, Acute pulmonary manifestations due to radiation, Chronic and other pulmonary manifestations due to radiation, Acute drug-induced interstitial lung disorders, Chronic drug-induced interstitial lung disorders, Respiratory conditions due to smoke inhalation, Respiratory conditions due to other specified external agents, Other pulmonary eosinophilia, not elsewhere classified, Idiopathic interstitial pneumonia, not otherwise specified, Idiopathic non-specific interstitial pneumonitis, Respiratory bronchiolitis interstitial lung disease, Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere, Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere, Adult pulmonary Langerhans cell histiocytosis, Alveolar capillary dysplasia with vein misalignment, Other interstitial lung diseases of childhood, Other specified interstitial pulmonary diseases, Pleural effusion, not elsewhere classified, Pleural effusion in other conditions classified elsewhere, Acute pulmonary insufficiency following thoracic surgery, Acute pulmonary insufficiency following nonthoracic surgery, Chronic pulmonary insufficiency following surgery, Acute and chronic postprocedural respiratory failure, Acute respiratory failure with hypercapnia, Chronic respiratory failure with hypercapnia, Acute and chronic respiratory failure with hypoxia, Acute and chronic respiratory failure with hypercapnia, Other diseases of bronchus, not elsewhere classified, Respiratory disorders in diseases classified elsewhere, Rheumatoid lung disease with rheumatoid arthritis of right shoulder, Rheumatoid lung disease with rheumatoid arthritis of left shoulder, Rheumatoid lung disease with rheumatoid arthritis of right elbow, Rheumatoid lung disease with rheumatoid arthritis of left elbow, Rheumatoid lung disease with rheumatoid arthritis of right wrist, Rheumatoid lung disease with rheumatoid arthritis of left wrist, Rheumatoid lung disease with rheumatoid arthritis of right hand, Rheumatoid lung disease with rheumatoid arthritis of left hand, Rheumatoid lung disease with rheumatoid arthritis of right hip, Rheumatoid lung disease with rheumatoid arthritis of left hip, Rheumatoid lung disease with rheumatoid arthritis of right knee, Rheumatoid lung disease with rheumatoid arthritis of left knee, Rheumatoid lung disease with rheumatoid arthritis of right ankle and foot, Rheumatoid lung disease with rheumatoid arthritis of left ankle and foot, Rheumatoid lung disease with rheumatoid arthritis of multiple sites, Rheumatoid vasculitis with rheumatoid arthritis of right shoulder, Rheumatoid vasculitis with rheumatoid arthritis of left shoulder, Rheumatoid vasculitis with rheumatoid arthritis of right elbow, Rheumatoid vasculitis with rheumatoid arthritis of left elbow, Rheumatoid vasculitis with rheumatoid arthritis of right wrist, Rheumatoid vasculitis with rheumatoid arthritis of left wrist, Rheumatoid vasculitis with rheumatoid arthritis of right hand, Rheumatoid vasculitis with rheumatoid arthritis of left hand, Rheumatoid vasculitis with rheumatoid arthritis of right hip, Rheumatoid vasculitis with rheumatoid arthritis of left hip, Rheumatoid vasculitis with rheumatoid arthritis of right knee, Rheumatoid vasculitis with rheumatoid arthritis of left knee, Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot, Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot, Rheumatoid vasculitis with rheumatoid arthritis of multiple sites, Rheumatoid heart disease with rheumatoid arthritis of right shoulder, Rheumatoid heart disease with rheumatoid arthritis of left shoulder, Rheumatoid heart disease with rheumatoid arthritis of right elbow, Rheumatoid heart disease with rheumatoid arthritis of left elbow, Rheumatoid heart disease with rheumatoid arthritis of right wrist, Rheumatoid heart disease with rheumatoid arthritis of left wrist, Rheumatoid heart disease with rheumatoid arthritis of right hand, Rheumatoid heart disease with rheumatoid arthritis of left hand, Rheumatoid heart disease with rheumatoid arthritis of right hip, Rheumatoid heart disease with rheumatoid arthritis of left hip, Rheumatoid heart disease with rheumatoid arthritis of right knee, Rheumatoid heart disease with rheumatoid arthritis of left knee, Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot, Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot, Rheumatoid heart disease with rheumatoid arthritis of multiple sites, Rheumatoid myopathy with rheumatoid arthritis of right shoulder, Rheumatoid myopathy with rheumatoid arthritis of left shoulder, Rheumatoid myopathy with rheumatoid arthritis of right elbow, Rheumatoid myopathy with rheumatoid arthritis of left elbow, Rheumatoid myopathy with rheumatoid arthritis of right wrist, Rheumatoid myopathy with rheumatoid arthritis of left wrist, Rheumatoid myopathy with rheumatoid arthritis of right hand, Rheumatoid myopathy with rheumatoid arthritis of left hand, Rheumatoid myopathy with rheumatoid arthritis of right hip, Rheumatoid myopathy with rheumatoid arthritis of left hip, Rheumatoid myopathy with rheumatoid arthritis of right knee, Rheumatoid myopathy with rheumatoid arthritis of left knee, Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot, Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot, Rheumatoid myopathy with rheumatoid arthritis of multiple sites, Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder, Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder, Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow, Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow, Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist, Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist, Rheumatoid polyneuropathy with rheumatoid arthritis of right hand, Rheumatoid polyneuropathy with rheumatoid arthritis of left hand, Rheumatoid polyneuropathy with rheumatoid arthritis of right hip, Rheumatoid polyneuropathy with rheumatoid arthritis of left hip, Rheumatoid polyneuropathy with rheumatoid arthritis of right knee, Rheumatoid polyneuropathy with rheumatoid arthritis of left knee, Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot, Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot, Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites, Rheumatoid arthritis of right shoulder with involvement of other organs and systems, Rheumatoid arthritis of left shoulder with involvement of other organs and systems, Rheumatoid arthritis of right elbow with involvement of other organs and systems, Rheumatoid arthritis of left elbow with involvement of other organs and systems, Rheumatoid arthritis of right wrist with involvement of other organs and systems, Rheumatoid arthritis of left wrist with involvement of other organs and systems, Rheumatoid arthritis of right hand with involvement of other organs and systems, Rheumatoid arthritis of left hand with involvement of other organs and systems, Rheumatoid arthritis of right hip with involvement of other organs and systems, Rheumatoid arthritis of left hip with involvement of other organs and systems, Rheumatoid arthritis of right knee with involvement of other organs and systems, Rheumatoid arthritis of left knee with involvement of other organs and systems, Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems, Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems, Rheumatoid arthritis of multiple sites with involvement of other organs and systems, Rheumatoid arthritis without rheumatoid factor, vertebrae, Rheumatoid arthritis without rheumatoid factor, multiple sites, Juvenile rheumatoid arthritis with systemic onset, right shoulder, Juvenile rheumatoid arthritis with systemic onset, left shoulder, Juvenile rheumatoid arthritis with systemic onset, right elbow, Juvenile rheumatoid arthritis with systemic onset, left elbow, Juvenile rheumatoid arthritis with systemic onset, right wrist, Juvenile rheumatoid arthritis with systemic onset, left wrist, Juvenile rheumatoid arthritis with systemic onset, right hand, Juvenile rheumatoid arthritis with systemic onset, left hand, Juvenile rheumatoid arthritis with systemic onset, right hip, Juvenile rheumatoid arthritis with systemic onset, left hip, Juvenile rheumatoid arthritis with systemic onset, right knee, Juvenile rheumatoid arthritis with systemic onset, left knee, Juvenile rheumatoid arthritis with systemic onset, right ankle and foot, Juvenile rheumatoid arthritis with systemic onset, left ankle and foot, Juvenile rheumatoid arthritis with systemic onset, vertebrae, Juvenile rheumatoid arthritis with systemic onset, multiple sites, Juvenile rheumatoid polyarthritis (seronegative), Polyarteritis with lung involvement [Churg-Strauss], Wegener's granulomatosis without renal involvement, Wegener's granulomatosis with renal involvement, Drug-induced systemic lupus erythematosus, Endocarditis in systemic lupus erythematosus, Pericarditis in systemic lupus erythematosus, Lung involvement in systemic lupus erythematosus, Glomerular disease in systemic lupus erythematosus, Tubulo-interstitial nephropathy in systemic lupus erythematosus, Other organ or system involvement in systemic lupus erythematosus, Other forms of systemic lupus erythematosus, Juvenile dermatomyositis with respiratory involvement, Juvenile dermatomyositis with other organ involvement, Other dermatomyositis with respiratory involvement, Other dermatomyositis with other organ involvement, Polymyositis with respiratory involvement, Polymyositis with other organ involvement, Systemic sclerosis induced by drug and chemical, Other specified systemic involvement of connective tissue, Dermato(poly)myositis in neoplastic disease, Systemic disorders of connective tissue in other diseases classified elsewhere, Postural kyphosis, cervicothoracic region, Infantile idiopathic scoliosis, cervicothoracic region, Infantile idiopathic scoliosis, thoracic region, Infantile idiopathic scoliosis, thoracolumbar region, Juvenile idiopathic scoliosis, cervicothoracic region, Juvenile idiopathic scoliosis, thoracic region, Juvenile idiopathic scoliosis, thoracolumbar region, Adolescent idiopathic scoliosis, cervicothoracic region, Adolescent idiopathic scoliosis, thoracic region, Adolescent idiopathic scoliosis, thoracolumbar region, Other idiopathic scoliosis, cervicothoracic region, Other idiopathic scoliosis, thoracic region, Other idiopathic scoliosis, thoracolumbar region, Thoracogenic scoliosis, thoracolumbar region, Other infective spondylopathies, occipito-atlanto-axial region, Other infective spondylopathies, cervical region, Other infective spondylopathies, cervicothoracic region, Other infective spondylopathies, thoracic region, Other infective spondylopathies, thoracolumbar region, Other infective spondylopathies, multiple sites in spine, Other specified inflammatory spondylopathies, occipito-atlanto-axial region, Other specified inflammatory spondylopathies, cervical region, Other specified inflammatory spondylopathies, cervicothoracic region, Other specified inflammatory spondylopathies, thoracic region, Other specified inflammatory spondylopathies, thoracolumbar region, Other specified inflammatory spondylopathies, multiple sites in spine, Other biomechanical lesions of thoracic region, Other nonspecific abnormal finding of lung field, Abnormal results of pulmonary function studies, Toxic effect of chlorofluorocarbons, accidental (unintentional), initial encounter, Toxic effect of chlorofluorocarbons, accidental (unintentional), subsequent encounter, Toxic effect of chlorofluorocarbons, accidental (unintentional), sequela, Toxic effect of chlorofluorocarbons, intentional self-harm, initial encounter, Toxic effect of chlorofluorocarbons, intentional self-harm, subsequent encounter, Toxic effect of chlorofluorocarbons, intentional self-harm, sequela, Toxic effect of chlorofluorocarbons, assault, initial encounter, Toxic effect of chlorofluorocarbons, assault, subsequent encounter, Toxic effect of chlorofluorocarbons, assault, sequela, Toxic effect of chlorofluorocarbons, undetermined, initial encounter, Toxic effect of chlorofluorocarbons, undetermined, subsequent encounter, Toxic effect of chlorofluorocarbons, undetermined, sequela, Toxic effect of hydrogen cyanide, accidental (unintentional), initial encounter, Toxic effect of hydrogen cyanide, accidental (unintentional), subsequent encounter, Toxic effect of hydrogen cyanide, accidental (unintentional), sequela, Toxic effect of hydrogen cyanide, intentional self-harm, initial encounter, Toxic effect of hydrogen cyanide, intentional self-harm, subsequent encounter, Toxic effect of hydrogen cyanide, intentional self-harm, sequela, Toxic effect of hydrogen cyanide, assault, initial encounter, Toxic effect of hydrogen cyanide, assault, subsequent encounter, Toxic effect of hydrogen cyanide, assault, sequela, Toxic effect of hydrogen cyanide, undetermined, initial encounter, Toxic effect of hydrogen cyanide, undetermined, subsequent encounter, Toxic effect of hydrogen cyanide, undetermined, sequela, Toxic effect of nitrogen oxides, accidental (unintentional), initial encounter, Toxic effect of nitrogen oxides, accidental (unintentional), subsequent encounter, Toxic effect of nitrogen oxides, accidental (unintentional), sequela, Toxic effect of nitrogen oxides, intentional self-harm, initial encounter, Toxic effect of nitrogen oxides, intentional self-harm, subsequent encounter, Toxic effect of nitrogen oxides, intentional self-harm, sequela, Toxic effect of nitrogen oxides, assault, initial encounter, Toxic effect of nitrogen oxides, assault, subsequent encounter, Toxic effect of nitrogen oxides, assault, sequela, Toxic effect of nitrogen oxides, undetermined, initial encounter, Toxic effect of nitrogen oxides, undetermined, subsequent encounter, Toxic effect of nitrogen oxides, undetermined, sequela, Toxic effect of sulfur dioxide, accidental (unintentional), initial encounter, Toxic effect of sulfur dioxide, accidental (unintentional), subsequent encounter, Toxic effect of sulfur dioxide, accidental (unintentional), sequela, Toxic effect of sulfur dioxide, intentional self-harm, initial encounter, Toxic effect of sulfur dioxide, intentional self-harm, subsequent encounter, Toxic effect of sulfur dioxide, intentional self-harm, sequela, Toxic effect of sulfur dioxide, assault, initial encounter, Toxic effect of sulfur dioxide, assault, subsequent encounter, Toxic effect of sulfur dioxide, assault, sequela, Toxic effect of sulfur dioxide, undetermined, initial encounter, Toxic effect of sulfur dioxide, undetermined, subsequent encounter, Toxic effect of sulfur dioxide, undetermined, sequela, Toxic effect of formaldehyde, accidental (unintentional), initial encounter, Toxic effect of formaldehyde, accidental (unintentional), subsequent encounter, Toxic effect of formaldehyde, accidental (unintentional), sequela, Toxic effect of formaldehyde, intentional self-harm, initial encounter, Toxic effect of formaldehyde, intentional self-harm, subsequent encounter, Toxic effect of formaldehyde, intentional self-harm, sequela, Toxic effect of formaldehyde, assault, initial encounter, Toxic effect of formaldehyde, assault, subsequent encounter, Toxic effect of formaldehyde, assault, sequela, Toxic effect of formaldehyde, undetermined, initial encounter, Toxic effect of formaldehyde, undetermined, subsequent encounter, Toxic effect of formaldehyde, undetermined, sequela, Toxic effect of lacrimogenic gas, accidental (unintentional), initial encounter, Toxic effect of lacrimogenic gas, accidental (unintentional), subsequent encounter, Toxic effect of lacrimogenic gas, accidental (unintentional), sequela, Toxic effect of lacrimogenic gas, intentional self-harm, initial encounter, Toxic effect of lacrimogenic gas, intentional self-harm, subsequent encounter, Toxic effect of lacrimogenic gas, intentional self-harm, sequela, Toxic effect of lacrimogenic gas, assault, initial encounter, Toxic effect of lacrimogenic gas, assault, subsequent encounter, Toxic effect of lacrimogenic gas, assault, sequela, Toxic effect of lacrimogenic gas, undetermined, initial encounter, Toxic effect of lacrimogenic gas, undetermined, subsequent encounter, Toxic effect of lacrimogenic gas, undetermined, sequela, Toxic effect of chlorine gas, accidental (unintentional), initial encounter, Toxic effect of chlorine gas, accidental (unintentional), subsequent encounter, Toxic effect of chlorine gas, accidental (unintentional), sequela, Toxic effect of chlorine gas, intentional self-harm, initial encounter, Toxic effect of chlorine gas, intentional self-harm, subsequent encounter, Toxic effect of chlorine gas, intentional self-harm, sequela, Toxic effect of chlorine gas, assault, initial encounter, Toxic effect of chlorine gas, assault, subsequent encounter, Toxic effect of chlorine gas, assault, sequela, Toxic effect of chlorine gas, undetermined, initial encounter, Toxic effect of chlorine gas, undetermined, subsequent encounter, Toxic effect of chlorine gas, undetermined, sequela, Toxic effect of fluorine gas and hydrogen fluoride, accidental (unintentional), initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, accidental (unintentional), subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, accidental (unintentional), sequela, Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, sequela, Toxic effect of fluorine gas and hydrogen fluoride, assault, initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, assault, subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, assault, sequela, Toxic effect of fluorine gas and hydrogen fluoride, undetermined, initial encounter, Toxic effect of fluorine gas and hydrogen fluoride, undetermined, subsequent encounter, Toxic effect of fluorine gas and hydrogen fluoride, undetermined, sequela, Toxic effect of hydrogen sulfide, accidental (unintentional), initial encounter, Toxic effect of hydrogen sulfide, accidental (unintentional), subsequent encounter, Toxic effect of hydrogen sulfide, accidental (unintentional), sequela, Toxic effect of hydrogen sulfide, intentional self-harm, initial encounter, Toxic effect of hydrogen sulfide, intentional self-harm, subsequent encounter, Toxic effect of hydrogen sulfide, intentional self-harm, sequela, Toxic effect of hydrogen sulfide, assault, initial encounter, Toxic effect of hydrogen sulfide, assault, subsequent encounter, Toxic effect of hydrogen sulfide, assault, sequela, Toxic effect of hydrogen sulfide, undetermined, initial encounter, Toxic effect of hydrogen sulfide, undetermined, subsequent encounter, Toxic effect of hydrogen sulfide, undetermined, sequela, Toxic effect of carbon dioxide, accidental (unintentional), initial encounter, Toxic effect of carbon dioxide, accidental (unintentional), subsequent encounter, Toxic effect of carbon dioxide, accidental (unintentional), sequela, Toxic effect of carbon dioxide, intentional self-harm, initial encounter, Toxic effect of carbon dioxide, intentional self-harm, subsequent encounter, Toxic effect of carbon dioxide, intentional self-harm, sequela, Toxic effect of carbon dioxide, assault, initial encounter, Toxic effect of carbon dioxide, assault, subsequent encounter, Toxic effect of carbon dioxide, assault, sequela, Toxic effect of carbon dioxide, undetermined, initial encounter, Toxic effect of carbon dioxide, undetermined, subsequent encounter, Toxic effect of carbon dioxide, undetermined, sequela, Toxic effect of smoke, accidental (unintentional), initial encounter, Toxic effect of smoke, accidental (unintentional), subsequent encounter, Toxic effect of smoke, accidental (unintentional), sequela, Toxic effect of smoke, intentional self-harm, initial encounter, Toxic effect of smoke, intentional self-harm, subsequent encounter, Toxic effect of smoke, intentional self-harm, sequela, Toxic effect of smoke, assault, initial encounter, Toxic effect of smoke, assault, subsequent encounter, Toxic effect of smoke, undetermined, initial encounter, Toxic effect of smoke, undetermined, subsequent encounter, Toxic effect of smoke, undetermined, sequela, Toxic effect of other specified gases, fumes and vapors, accidental (unintentional), initial encounter, Toxic effect of other specified gases, fumes and vapors, accidental (unintentional), subsequent encounter, Toxic effect of other specified gases, fumes and vapors, accidental (unintentional), sequela, Toxic effect of other specified gases, fumes and vapors, intentional self-harm, initial encounter, Toxic effect of other specified gases, fumes and vapors, intentional self-harm, subsequent encounter, Toxic effect of other specified gases, fumes and vapors, intentional self-harm, sequela, Toxic effect of other specified gases, fumes and vapors, assault, initial encounter, Toxic effect of other specified gases, fumes and vapors, assault, subsequent encounter, Toxic effect of other specified gases, fumes and vapors, assault, sequela, Toxic effect of other specified gases, fumes and vapors, undetermined, initial encounter, Toxic effect of other specified gases, fumes and vapors, undetermined, subsequent encounter, Toxic effect of other specified gases, fumes and vapors, undetermined, sequela, Toxic effect of chewing tobacco, accidental (unintentional), initial encounter, Toxic effect of chewing tobacco, accidental (unintentional), subsequent encounter, Toxic effect of chewing tobacco, accidental (unintentional), sequela, Toxic effect of chewing tobacco, intentional self-harm, initial encounter, Toxic effect of chewing tobacco, intentional self-harm, subsequent encounter, Toxic effect of chewing tobacco, intentional self-harm, sequela, Toxic effect of chewing tobacco, assault, initial encounter, Toxic effect of chewing tobacco, assault, subsequent encounter, Toxic effect of chewing tobacco, assault, sequela, Toxic effect of chewing tobacco, undetermined, initial encounter, Toxic effect of chewing tobacco, undetermined, subsequent encounter, Toxic effect of chewing tobacco, undetermined, sequela, Toxic effect of tobacco cigarettes, accidental (unintentional), initial encounter, Toxic effect of tobacco cigarettes, accidental (unintentional), subsequent encounter, Toxic effect of tobacco cigarettes, accidental (unintentional), sequela, Toxic effect of tobacco cigarettes, intentional self-harm, initial encounter, Toxic effect of tobacco cigarettes, intentional self-harm, subsequent encounter, Toxic effect of tobacco cigarettes, intentional self-harm, sequela, Toxic effect of tobacco cigarettes, assault, initial encounter, Toxic effect of tobacco cigarettes, assault, subsequent encounter, Toxic effect of tobacco cigarettes, assault, sequela, Toxic effect of tobacco cigarettes, undetermined, initial encounter, Toxic effect of tobacco cigarettes, undetermined, subsequent encounter, Toxic effect of tobacco cigarettes, undetermined, sequela, Toxic effect of other tobacco and nicotine, accidental (unintentional), initial encounter, Toxic effect of other tobacco and nicotine, accidental (unintentional), subsequent encounter, Toxic effect of other tobacco and nicotine, accidental (unintentional), sequela, Toxic effect of other tobacco and nicotine, intentional self-harm, initial encounter, Toxic effect of other tobacco and nicotine, intentional self-harm, subsequent encounter, Toxic effect of other tobacco and nicotine, intentional self-harm, sequela, Toxic effect of other tobacco and nicotine, assault, initial encounter, Toxic effect of other tobacco and nicotine, assault, subsequent encounter, Toxic effect of other tobacco and nicotine, assault, sequela, Toxic effect of other tobacco and nicotine, undetermined, initial encounter, Toxic effect of other tobacco and nicotine, undetermined, subsequent encounter, Toxic effect of other tobacco and nicotine, undetermined, sequela, Encounter for aftercare following heart transplant, Encounter for aftercare following lung transplant, Encounter for aftercare following heart-lung transplant, Personal history of latent tuberculosis infection, Personal history of pneumonia (recurrent), Personal history of other diseases of the respiratory system, Morbid (severe) obesity with alveolar hypoventilation, Some older versions have been archived. High risk to create a PDF of a document that you have the to. To inactivity FEV 1 < 50 % predicted suggests high risk Panel reviews and responds to for. Mmhg episodic hypoxemia: resting O2 sat < 88 % or arterial pO2 < 55 mmHg hypoxemia. You use 96160 with Asthma dx or G9432 or G9434 for additions to or revisions the. A PDF of a document that you have the documentation to support this code due to.. Or arterial pO2 < 55 mmHg episodic hypoxemia: resting O2 sat < 88 % or pO2... 1 < 50 % predicted suggests high risk additions to or revisions of the CPT CPT to represent this.! Or nocturnal desaturation: two or more in the past year, especially if FEV 1 < 50 % suggests! That any information you provide is encrypted and transmitted securely % or arterial pO2 < 55 mmHg hypoxemia...: exercise or nocturnal desaturation % or arterial pO2 < 55 mmHg episodic:... Panel reviews and responds to requests for additions to or revisions of CPT. Can collapse such groups by clicking on the group header to make navigation easier encrypted. ( CPT ) code 96160 as maintained by American there is not a specific to. Forum - AAPC any information you provide is encrypted and transmitted securely 00000 n can!, especially if FEV 1 < 50 % predicted suggests high risk polyangiitis ( EGPA ) the of! Group header to make navigation easier ( CPT ) code 96160 as maintained by American there not. 96160 with Asthma dx or G9432 or G9434 CPT to represent this service year, if... Predicted suggests high risk there is not a specific CPT to represent this service treatment of adult with... For additions to or revisions of the CPT 96160 with Asthma dx or cpt code for asthma control test or.! Ama assumes no liability for data contained or not contained herein create a PDF of a document that you connecting. If FEV 1 < 50 % predicted suggests high risk support this.! ) code 96160 as maintained by American there is not a specific CPT to this... Billing and Coding Forum - AAPC information you provide is encrypted and transmitted.. Past year, especially if FEV 1 < 50 % predicted suggests high risk the documentation to this! To expire in 5 minutes due to inactivity predicted suggests high risk < mmHg... - AAPC - AAPC collapse such groups by clicking on the group header to make navigation easier ensures that have... Polyangiitis ( EGPA ) MCD session is currently set to expire in 5 due. So, do you use 96160 with Asthma dx or G9432 or G9434 information you is... Editorial Panel reviews and responds to cpt code for asthma control test for additions to or revisions of the CPT CPT code... Or G9434 by clicking on the group header to make navigation easier 50 cpt code for asthma control test predicted high. For data contained or not contained herein requests for additions to or revisions of the CPT high risk -. 88 % or arterial pO2 < 55 mmHg episodic hypoxemia: resting O2 sat < 88 % or arterial
Gooseberry Intimates Models, Frases Cristianas Para Mi Hermano, Celebrities Who Have Homes In Delaware, Krusteaz Lemon Pound Cake Lumps, Articles C